loading
전일 마감가:
$10.07
열려 있는:
$10.09
하루 거래량:
184.07K
Relative Volume:
2.79
시가총액:
$236.81M
수익:
순이익/손실:
주가수익비율:
-3,737.04
EPS:
-0.0027
순현금흐름:
1주 성능:
+0.20%
1개월 성능:
-0.10%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
Value
$0.00
$0.00
1주일 범위
Value
$10.07
$10.09
52주 변동 폭
Value
$9.93
$10.10

Apogee Acquisition Corp Stock (AACP) Company Profile

Name
명칭
Apogee Acquisition Corp
Name
전화
771.210.4643
Name
주소
2106 HOUSE AVE SUITE 375, CHEYENNE
Name
직원
3
Name
트위터
Name
다음 수익 날짜
null
Name
최신 SEC 제출 서류
Name
AACP's Discussions on Twitter

Compare AACP vs VYLR, DMII, EVAC, BCSS, CEPF

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
AACP icon
AACP
Apogee Acquisition Corp
10.09 236.81M 0 0 0 -0.0027
VYLR icon
VYLR
Vylor Inc.
71.12 47.46B 0 0 0 0.00
DMII icon
DMII
Drugs Made In America Acquisition Ii Corp
10.19 649.10M 0 8.58M -1.11M 0.134
EVAC icon
EVAC
Eqv Ventures Acquisition Corp Ii
10.34 604.35M 0 12.80M -714.00K 0.2184
BCSS icon
BCSS
Bain Capital Gss Investment Corp
10.21 595.97M 0 8.29M -686.50K 0.142
CEPF icon
CEPF
Cantor Equity Partners Iv Inc
10.28 587.50M 0 10.29M -337.90K 0.1801

Apogee Acquisition Corp 주식(AACP)의 최신 뉴스

pulisher
Oct 19, 2026

Apogee Acquisition Restates Q2 2026 Financials, Director and COO Resign - Minichart

Oct 19, 2026
pulisher
Oct 17, 2026

Form 4 Apogee Acquisition Corp: APOGEE ACQUISITION SPONSOR LLC (10% Owner) For: 13 October - Investing.com Nigeria

Oct 17, 2026
pulisher
Oct 16, 2026

Form 4 Apogee Acquisition Corp: Thomas Lloyd Watson (COO) For: 14 October - Investing.com Nigeria

Oct 16, 2026
pulisher
Oct 16, 2026

Q2 errors surface at Apogee Acquisition (AACPR) as its COO and a director resign. - Stock Titan

Oct 16, 2026
pulisher
Oct 16, 2026

Financial statements are unchanged as Apogee Acquisition Corp (AACPR) amends share and warrant counts. - Stock Titan

Oct 16, 2026
pulisher
Sep 25, 2026

Pinnacle Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 25, 2026 - Yahoo Finance

Sep 25, 2026
pulisher
Sep 22, 2026

Accelevation Launches Roadshow for Proposed IPO of 30 Million Shares - Yahoo Finance

Sep 22, 2026
pulisher
Sep 16, 2026

Apogee Enterprises Director Julie K. Streich Receives 2,530 Shares in Award on September 11, 2026 - Kalkine Media

Sep 16, 2026
pulisher
Sep 15, 2026

Apogee Enterprises Director Julie K. Streich Acquires 2,530 Shares at No Cost - Kalkine Media

Sep 15, 2026
pulisher
Sep 11, 2026

abrdn Income Credit Strategies Fund cuts monthl... - Pluang

Sep 11, 2026
pulisher
Sep 11, 2026

abrdn Income Credit Strategies Fund (ACP) Announces Change to Monthly Distribution Expected to Be Maintained for at Least the Next 12 Months - TradingView

Sep 11, 2026
pulisher
Sep 11, 2026

abrdn Income Credit Strategies Fund cuts monthly distribution to $0.055 per share from $0.0775 - Bitget

Sep 11, 2026
pulisher
Sep 11, 2026

Aperture AC to Take Atlantic HPC Public in $150 Million Deal - Yahoo Finance

Sep 11, 2026
pulisher
Sep 08, 2026

Apogee Therapeutics (NASDAQ: APGE) leaves Nasdaq in AbbVie cash buyout - Stock Titan

Sep 08, 2026
pulisher
Sep 08, 2026

Shareholders will receive $0.328125 per share on Sept. 30 - Stock Titan

Sep 08, 2026
pulisher
Sep 05, 2026

Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - Eastern Progress

Sep 05, 2026
pulisher
Sep 03, 2026

AbbVie-owned Apogee Therapeutics (APGE) pulls unsold stock - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

Apogee Therapeutics (APGE) director-linked funds fully exit in AbbVie deal - stocktitan.net

Sep 03, 2026
pulisher
Sep 03, 2026

Apogee Therapeutics (APGE) CMO cashes out stock and options in AbbVie deal - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

Director cashes out Apogee (NASDAQ: APGE) stake in AbbVie merger - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

Apogee merger pays $135.11 per share in cash | APGE SEC FilingForm SCHEDULE 13D/A - stocktitan.net

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie Finalizes $10.9 Billion Acquisition of Apogee Therapeutics, Initiates Nasdaq Delisting - Kalkine Media

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline - Dermatology Times

Sep 03, 2026
pulisher
Sep 03, 2026

ACP/PA Stock Price and Chart — NYSE:ACP/PA - TradingView

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie Completes Acquisition of Apogee Therapeutics - Investing News Network

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie Completes $10.9 Billion Acquisition of Apogee Therapeutics - minichart.com.sg

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie Completes $10.9 Billion Apogee Acquisition, Reaffirms 2026 EPS Guidance - Minichart

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio - TipRanks

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie seals $11B acquisition of Apogee Therapeutics (ABBV:NYSE) - Seeking Alpha

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie Completes Acquisition of Apogee Therapeutics - finance.yahoo.com

Sep 03, 2026
pulisher
Sep 03, 2026

Apogee Therapeutics (APGE) CEO’s stock and options paid out in AbbVie deal - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

AbbVie’s $10.9 billion deal adds a late-stage eczema treatment - Stock Titan

Sep 03, 2026
pulisher
Sep 02, 2026

TOMI Regains Nasdaq Equity Compliance After $2.5M Debt Conversion - minichart.com.sg

Sep 02, 2026
pulisher
Sep 01, 2026

ACP Edges Lower by 0.59%: abrdn Income Credit Strategies Fund Holds Above Key SupportRounding Top - dars.gov.et

Sep 01, 2026
pulisher
Aug 30, 2026

abrdn Income Credit Strategies Fund (ACP) Ticks Up 1.39% as Shares Hold Above Key SupportIndex Put Call - vinanet.vn

Aug 30, 2026
pulisher
Aug 20, 2026

ARISTEIA CAPITAL, L.L.C. Initiates Position in Apogee Acquisitio - GuruFocus

Aug 20, 2026
pulisher
Aug 20, 2026

ABBV climbs around 1.5% after double-digit revenue growth and Apogee acquisition - Traders Union

Aug 20, 2026
pulisher
Aug 20, 2026

Apogee Acquisition Corp Q2 2026: Net income $1.13M, EPS $0.08— 10-Q Summary - TradingView

Aug 20, 2026
pulisher
Aug 20, 2026

Apogee Acquisition (AACP) faces 2027 deal-or-liquidation deadline - Stock Titan

Aug 20, 2026
pulisher
Aug 20, 2026

Apogee Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 20, 2026
pulisher
Aug 20, 2026

Abrdn Income Credit Strategies Fund flagged as sell due to unsustainable yields and NAV erosion risks. - Pluang

Aug 20, 2026
pulisher
Aug 20, 2026

ACP: NAV Erosion Will Continue (NYSE:ACP) - Seeking Alpha

Aug 20, 2026
pulisher
Aug 18, 2026

AbbVie Raises $10 Billion in Debt to Fund Apogee Acquisition - Minichart

Aug 18, 2026
pulisher
Aug 18, 2026

AbbVie Completes $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition - Kalkine Media

Aug 18, 2026
pulisher
Aug 18, 2026

AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com

Aug 18, 2026
pulisher
Aug 18, 2026

AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com UK

Aug 18, 2026
pulisher
Aug 18, 2026

AbbVie (NYSE: ABBV) issues new senior notes with Apogee-linked redemption - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

AbbVie Inc Stock (ABBV) Closed Up by 3.48% on Aug 18: Key Drivers Unveiled - TradingKey

Aug 18, 2026
pulisher
Aug 18, 2026

Osprey Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 21, 2026 - Yahoo Finance

Aug 18, 2026
pulisher
Aug 14, 2026

Apogee Acquisition Corp SEC Filing (Aug 14, 2026) - Stock Titan

Aug 14, 2026

Apogee Acquisition Corp (AACP) 재무 분석

Apogee Acquisition Corp (AACP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$10.07
price up icon 0.00%
$10.12
price down icon 0.10%
$10.12
price down icon 0.10%
$10.61
price up icon 0.09%
$10.20
price up icon 0.05%
$9.98
price up icon 0.20%
자본화:     |  볼륨(24시간):